Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Viruses
Entry Details
ID
2296
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
O70902 (Created: 2006-06-27 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name
ENV_HV190
Protein Name
Envelope glycoprotein gp160
Gene
env
Organism Scientific
Human immunodeficiency virus type 1 (isolate 90CF056 group M subtype H)
Organism Common
HIV-1
Lineage
Viruses
Retro-transcribing viruses
Retroviridae
Orthoretrovirinae
Lentivirus
Primate lentivirus group
Protein Length [aa]
845
Protein Mass [Da]
95827
Features
Type
Description
Status
Start
End
signal peptide
by similarity
1
28
chain
Envelope glycoprotein gp160
by similarity
29
845
chain
Surface protein
by similarity
29
500
chain
Transmembrane protein
by similarity
501
845
disulfide bond
by similarity
50
70
disulfide bond
by similarity
115
198
disulfide bond
by similarity
122
189
disulfide bond
by similarity
127
150
disulfide bond
by similarity
211
240
disulfide bond
by similarity
221
232
disulfide bond
by similarity
289
323
disulfide bond
by similarity
369
434
disulfide bond
by similarity
376
407
transmembrane region
potential
674
694
topological domain
Extracellular
potential
29
673
topological domain
Cytoplasmic
potential
695
845
region of interest
V1
127
149
region of interest
V2
150
189
region of interest
V3
289
322
region of interest
V4
376
407
region of interest
V5
450
460
region of interest
Fusion peptide
potential
501
521
region of interest
Immunosuppression
by similarity
565
581
region of interest
Involved in GalCer binding
by similarity
651
656
glycosylation site
N-linked (GlcNAc...)
potential
84
84
glycosylation site
N-linked (GlcNAc...)
potential
126
126
glycosylation site
N-linked (GlcNAc...)
potential
132
132
glycosylation site
N-linked (GlcNAc...)
potential
133
133
glycosylation site
N-linked (GlcNAc...)
potential
136
136
glycosylation site
N-linked (GlcNAc...)
potential
149
149
glycosylation site
N-linked (GlcNAc...)
potential
153
153
glycosylation site
N-linked (GlcNAc...)
potential
179
179
glycosylation site
N-linked (GlcNAc...)
potential
180
180
glycosylation site
N-linked (GlcNAc...)
potential
190
190
glycosylation site
N-linked (GlcNAc...)
potential
223
223
glycosylation site
N-linked (GlcNAc...)
potential
227
227
glycosylation site
N-linked (GlcNAc...)
potential
234
234
glycosylation site
N-linked (GlcNAc...)
potential
255
255
glycosylation site
N-linked (GlcNAc...)
potential
269
269
glycosylation site
N-linked (GlcNAc...)
potential
286
286
glycosylation site
N-linked (GlcNAc...)
potential
294
294
glycosylation site
N-linked (GlcNAc...)
potential
324
324
glycosylation site
N-linked (GlcNAc...)
potential
331
331
glycosylation site
N-linked (GlcNAc...)
potential
347
347
glycosylation site
N-linked (GlcNAc...)
potential
377
377
glycosylation site
N-linked (GlcNAc...)
potential
383
383
glycosylation site
N-linked (GlcNAc...)
potential
391
391
glycosylation site
N-linked (GlcNAc...)
potential
395
395
glycosylation site
N-linked (GlcNAc...)
potential
402
402
glycosylation site
N-linked (GlcNAc...)
potential
437
437
glycosylation site
N-linked (GlcNAc...)
potential
449
449
glycosylation site
N-linked (GlcNAc...)
potential
454
454
glycosylation site
N-linked (GlcNAc...)
potential
600
600
glycosylation site
N-linked (GlcNAc...)
potential
605
605
glycosylation site
N-linked (GlcNAc...)
potential
614
614
glycosylation site
N-linked (GlcNAc...)
potential
626
626
site
Cleavage; by host furin
by similarity
500
501
short sequence motif
YXXL motif; contains endocytosis signal
by similarity
701
704
coiled-coil region
potential
531
581
coiled-coil region
potential
622
656
SP Length
28
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
METQRNYPSLWRWGTLILGMLLICSAAQ
Sequence
METQRNYPSLWRWGTLILGMLLICSAAQ
NLWVTVYYGVPVWKEAKTTLFC
ASDAKAYETEKHNVWATHACVPTDPNPQEMVME
N
VTESFNMWENNMVEQM
HTDIISLWDQSLKPCVKLTPLCVTL
N
CTNVR
N
N
TS
N
STSSMEAGGELT
N
C
SF
N
VTTVLRDKQQKVHALFYRLDVVPID
N
N
STQYRLINC
N
TSVITQACPK
VSFEPIPIHYCAPAGFAILKCN
N
KTF
N
GTGLCT
N
VSTVQCTHGIRPVVST
QLLL
N
GSLAEEQIIIRTK
N
ISDNTKNIIVQLKTPV
N
IT
CTRPN
N
NTRTSI
HLGPGRAFYATGDIIGDIRQAH
C
N
ISRTDW
N
KTLHQVVTQLGIHLN
N
RTI
SFKPNSGGDMEVRTHSFNCRGEFFY
C
N
TSGLF
N
SSWEMHT
N
YTS
N
DTKGN
E
N
ITLPC
RIKQIVNMWQRVGRAMYAPPIQGNIMCVS
N
ITGLILTIDEG
N
A
SAE
N
YTFRPG
GGDMRDNWRSELYKYKVVKIEPLGIAPTKTRRRVVEREK
R
A
VGMGASFLGFLGAAGSTMGA
ASITLTVQA
RQLLSGIVQQQSNLLRAIQA
RQHMLQLTVWGIKQLQARVLAVERYLRDQQL
LGIWGCSGKLICTTNVPW
N
SSWS
N
KSQSEIWD
N
MTWMEWD
KQISNYTEEIYRLLEVSQTQQEKNEQDLL
ALDKWA
SLWTWFDISHWLWYIKI
FIMIVGGLIGLRIIFAVLSIV
NRVRQG
YSPL
SFQTLVPNPRGPDRPEGTEEGGGEQDRDRSVRLVNGFLPVVWDDLR
SLSLFSYRLLRDLLLIVVRTVELLGRRGREALKYLWNLLQYWGQELKNSA
IDLLNTTAIAVAEGTDGIIVIVQRAWRAILHIPRRIRQGFERSLL
Original
METQRNYPSLWRWGTLILGMLLICSAAQNLWVTVYYGVPVWKEAKTTLFC
ASDAKAYETEKHNVWATHACVPTDPNPQEMVMENVTESFNMWENNMVEQM
HTDIISLWDQSLKPCVKLTPLCVTLNCTNVRNNTSNSTSSMEAGGELTNC
SFNVTTVLRDKQQKVHALFYRLDVVPIDNNSTQYRLINCNTSVITQACPK
VSFEPIPIHYCAPAGFAILKCNNKTFNGTGLCTNVSTVQCTHGIRPVVST
QLLLNGSLAEEQIIIRTKNISDNTKNIIVQLKTPVNITCTRPNNNTRTSI
HLGPGRAFYATGDIIGDIRQAHCNISRTDWNKTLHQVVTQLGIHLNNRTI
SFKPNSGGDMEVRTHSFNCRGEFFYCNTSGLFNSSWEMHTNYTSNDTKGN
ENITLPCRIKQIVNMWQRVGRAMYAPPIQGNIMCVSNITGLILTIDEGNA
SAENYTFRPGGGDMRDNWRSELYKYKVVKIEPLGIAPTKTRRRVVEREKR
AVGMGASFLGFLGAAGSTMGAASITLTVQARQLLSGIVQQQSNLLRAIQA
RQHMLQLTVWGIKQLQARVLAVERYLRDQQLLGIWGCSGKLICTTNVPWN
SSWSNKSQSEIWDNMTWMEWDKQISNYTEEIYRLLEVSQTQQEKNEQDLL
ALDKWASLWTWFDISHWLWYIKIFIMIVGGLIGLRIIFAVLSIVNRVRQG
YSPLSFQTLVPNPRGPDRPEGTEEGGGEQDRDRSVRLVNGFLPVVWDDLR
SLSLFSYRLLRDLLLIVVRTVELLGRRGREALKYLWNLLQYWGQELKNSA
IDLLNTTAIAVAEGTDGIIVIVQRAWRAILHIPRRIRQGFERSLL
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11